James Stevens

Title: The Innovative Contributions of James Stevens

Introduction

James Stevens is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of medical research, particularly in the development of antibodies for influenza treatment. With a total of 2 patents, his work has the potential to impact public health positively.

Latest Patents

Stevens' latest patents include groundbreaking research on a potent anti-influenza A neuraminidase subtype N1 antibody. This patent discloses isolated monoclonal antibodies and antigen binding fragments that specifically bind to the neuraminidase (NA) of an N1 subtype influenza virus. These antibodies can be utilized for the detection of the N1 subtype influenza virus and for determining the immunogenicity of vaccines. Additionally, they can be employed in the treatment of subjects to prevent or ameliorate influenza infections. Another significant patent involves novel influenza antigens and immunogenic or vaccine compositions, along with methods for producing these antigens and compositions.

Career Highlights

Throughout his career, James Stevens has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and GlaxoSmithKline Biologicals SA. His experience in these institutions has allowed him to contribute to vital research and development in the field of immunology.

Collaborations

Stevens has collaborated with esteemed colleagues, including Hongquan Wan and David A Shore. These partnerships have further enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

James Stevens is a distinguished inventor whose work in developing antibodies for influenza treatment showcases his commitment to advancing medical science. His contributions have the potential to improve public health outcomes significantly.